L-NAME-treatment alters ectonucleotidase activities in kidney membranes of rats

Life Sciences

Volumn 87, Issue 9-10, 2010, Pages 325-332

  Fürstenau, Cristina Ribas ^a   Ramos, Denise Barbosa ^a   Vuaden, Fernanda Cenci ^a   Casali, Emerson André ^b   Monteiro, Priscilla de Souza ^c   Trentin, Danielle da Silva ^a   Gossenheimer, Agnes Nogueira ^a   Bogo, Maurício Reis ^d   Bonan, Carla Denise ^d   Barreto Chaves, Maria Luiza Morais ^c   Sarkis, João José Freitas ^a   Wofchuk, Susana Tchernin ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b IPA   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Adenosine; ATP; Ectonucleotidase; Hypertension; Kidney; L NAME; Rat

Indexed keywords

ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; CREATININE; ECTO 5' NUCLEOTIDASE; HYDROLASE; N(G) NITROARGININE METHYL ESTER; NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 2; NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 3; NUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 3; PHOSPHODIESTERASE; PROTEIN KINASE C; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOREGULATION; COLORIMETRY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; HYPERTENSION; KIDNEY FUNCTION; MALE; NONHUMAN; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTOLIC BLOOD PRESSURE;

ADENOSINE TRIPHOSPHATASES; ANIMALS; BLOOD PRESSURE; CELL MEMBRANE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CREATININE; DISEASE MODELS, ANIMAL; GENE EXPRESSION; HEART RATE; HYPERTENSION; KIDNEY; MALE; NG-NITROARGININE METHYL ESTER; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 77955768109     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2010.07.008     Document Type: Article

References (44)

1. Agteresch H.J., Dagnelie P.C., van den Berg J.W., Wilson J.H. Adenosine triphosphate: established and potential clinical applications. Drugs 1999, 58(2):211-232.
2. Bailey M.A., Turner C.M., Hus-Citharel A., Marchetti J., Imbert-Teboul M., Milner P., Burnstock G., Unwin R.J. P2Y receptors present in the native and isolated rat glomerulus. Nephron Physiology 2004, 96(3):79-90.
3. Balbinott A.W., Irigoyen M.C., Brasileiro-Santos M.S., Zottis B., de Lima N.G., Passaglia J., Schaan B.D. Dose-dependent autonomic dysfunction in chronic l-NAME-hypertensive diabetic rats. Journal of Cardiovascular Pharmacology 2005, 46(5):563-569.
4. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 1976, 72:248-254.
5. Burnstock G. Pathophysiology and therapeutic potential of purinergic signaling. Pharmacological Reviews 2006, 58(1):58-86.
6. Burnstock G., Knight G.E. Cellular distribution and functions of P2 receptor subtypes in different systems. International Review of Cytology 2004, 240:31-304.
7. Castrop H. Mediators of tubuloglomerular feedback regulation of glomerular filtration: ATP and adenosine. Acta Physiologica (Oxford) 2007, 189(1):3-14.
8. 2+-stimulated ATPase activity. Analytical Biochemistry 1986, 157(2):375-380.
9. Chan C.M., Unwin R.J., Bardini M., Oglesby I.B., Ford A.P., Townsend-Nicholson A., Burnstock G. Localization of P2X1 purinoceptors by autoradiography and immunohistochemistry in rat kidneys. American Journal of Physiology 1998, 274(4 Pt 2):F799-F804.
10. Goding J.W., Grobben B., Slegers H. Physiological and pathophysiological functions of the ecto-nucleotide pyrophosphatase/phosphodiesterase family. Biochimica Biophysica Acta 2003, 1638(1):1-19.
11. Guan Z., Osmond D.A., Inscho E.W. Purinoceptors in the kidney. Experimental Biology and Medicine (Maywood) 2007, 232(6):715-726.
12. Harahap A.R., Goding J.W. Distribution of the murine plasma cell antigen PC-1 in non-lymphoid tissues. Journal of Immunology 1988, 141(7):2317-2320.
13. Imig J.D., Inscho E.W. Adaptations of the renal microcirculation to hypertension. Microcirculation 2002, 9(4):315-328.
14. Inscho E.W. P2 receptors in regulation of renal microvascular function. American Journal of Physiology-Renal Physiology 2001, 280(6):F927-F944.
15. Inscho E.W., Ohishi K., Navar L.G. Effects of ATP on pre- and postglomerular juxtamedullary microvasculature. American Journal of Physiology 1992, 263(5 Pt 2):F886-F893.
16. Katsumi H., Nishikawa M., Hashida M. Development of nitric oxide donors for the treatment of cardiovascular diseases. Cardiovascular & Hematological Agents in Medicinal Chemistry 2007, 5(3):204-208.
17. Kirchner S.M., Bonan C.D., Battastini A.M., Sarkis J.J. Effect of nitric oxide donors on extracellular ATP, ADP, and AMP catabolism in rat hippocampal synaptosomes. Brain Research Bulletin 2001, 55(4):469-473.
18. Kishore B.K., Isaac J., Fausther M., Tripp S.R., Shi H., Gill P.S., Braun N., Zimmermann H., Sévigny J., Robson S.C. Expression of NTPDase1 and NTPDase2 in murine kidney: relevance to regulation of P2 receptor signaling. American Journal of Physiology - Renal Physiology 2005, 288(5):F1032-F1043.
19. Lemmens R., Kupers L., Sévigny J., Beaudoin A.R., Grondin G., Kittel A., Waelkens E., Vanduffel L. Purification, characterization, and localization of an ATP diphosphohydrolase in porcine kidney. American Journal of Physiology - Renal Physiology 2000, 278(6):F978-F988.
20. Lerman L.O., Chade A.R., Sica V., Napoli C. Animal models of hypertension: an overview. Journal of Laboratory and Clinical Medicine 2005, 146(3):160-173.
21. Nagy A., Delgado-Escueta A.V. Rapid preparation of synaptosomes from mammalian brain using nontoxic isoosmotic gradient material (Percoll). Journal of Neurochemistry 1984, 43(4):1114-1123.
22. Osswald H., Hermes H.H., Nabakowski G. Role of adenosine in signal transmission of tubuloglomerular feedback. Kidney International Supplement 1982, 12:S136-S142.
23. Pedrazza E.L., Rico E.P., Senger M.R., Pedrazza L., Zimmermann F.F., Sarkis J.J., Bogo M.R., Bonan C.D. Ecto-nucleotidase pathway is altered by different treatments with fluoxetine and nortriptyline. European Journal of Pharmacology 2008, 583(1):18-25.
24. Persson P.B. Renal blood flow autoregulation in blood pressure control. Current Opinion in Nephrology and Hypertension 2002, 11(1):67-72.
25. Rico E.P., Rosemberg D.B., Senger M.R., de Bem Arizi M., Dias R.D., Souto A.A., Bogo M.R., Bonan C.D. Ethanol and acetaldehyde alter NTPDase and 5'-nucleotidase from zebrafish brain membranes. Neurochemistry International 2008, 52(1-2):290-296.
26. Robson S.C., Sévigny J., Zimmermann H. The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance. Purinergic Signalling 2006, 2(2):409-430.
27. Rodrigues C.I.S., D'Avila R., Fernandes F.A., Almeida F.A. Rim e hipertensão arterial (Chapter 3.8). Hipertensão 2006, 86-93. Elsevier, Rio de Janeiro. A.A. Brandão, C. Amodeo, F. Nobre, F.D. Fuchs (Eds.).
28. Satriano J., Wead L., Cardus A., Deng A., Boss G.R., Thomson S.C., Blantz R.C. Regulation of ecto-5'-nucleotidase by NaCl and nitric oxide: potential roles in tubuloglomerular feedback and adaptation. American Journal of Physiology - Renal Physiology 2006, 291:F1078-F1082.
29. Schwiebert E.M. ATP release mechanisms, ATP receptors and purinergic signalling along the nephron. Clinical and Experimental Pharmacology and Physiology 2001, 28(4):340-350.
30. Tomson C.R., Petersen K., Heagerty A.M. Does treated essential hypertension result in renal impairment? A cohort study. Journal of Human Hypertension 1991, 5(3):189-192.
31. Turner C.M., Vonend O., Chan C., Burnstock G., Unwin R.J. The pattern of distribution of selected ATP-sensitive P2 receptor subtypes in normal rat kidney: an immunohistological study. Cells Tissues Organs 2003, 175(2):105-117.
32. Unwin R.J., Bailey M.A., Burnstock G. Purinergic signaling along the renal tubule: the current state of play. News in Physiological Sciences 2003, 18:237-241.
33. Vallon V. P2 receptors in the regulation of renal transport mechanisms. American Journal of Physiology - Renal Physiology 2008, 294(1):F10-F27.
34. Vekaria R.M., Shirley D.G., Sévigny J., Unwin R.J. Immunolocalization of ectonucleotidases along the rat nephron. American Journal of Physiology - Renal Physiology 2006, 290(2):F550-F560.
35. Vekaria R.M., Unwin R.J., Shirley D.G. Intraluminal ATP concentrations in rat renal tubules. Journal of the American Society of Nephrology 2006, 17(7):1841-1847.
36. Vieira V.P., Rocha J.B., Stefanello F.M., Balz D., Morsch V.M., Schetinger M.R. Heparin and chondroitin sulfate inhibit adenine nucleotide hydrolysis in liver and kidney membrane enriched fractions. The International Journal of Biochemistry & Cell Biology 2001, 33(12):1193-1201.
37. Vitzthum H., Weiss B., Bachleitner W., Kramer B.K., Kurtz A. Gene expression of adenosine receptors along the nephron. Kidney International 2004, 65(4):1180-1190.
38. Voelter W., Zech K., Arnold P., Ludwig G. Determination of selected pyrimidines, purines and their metabolites in serum and urine by reversed-phase ion-pair chromatography. Journal of Chromatography 1980, 199:345-354.
39. Vuaden F.C., Cognato G.P., Bonorino C., Bogo M.R., de Freitas Sarkis J.J., Bonan C.D. Lipopolysaccharide alters nucleotidase activities from lymphocytes and serum of rats. Life Sciences 2007, 80(19):1784-1791.
40. Whitworth J.A. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. Journal of Hypertension 2003, 21(11):1983-1992.
41. Yegutkin G.G. Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signaling cascade. Biochimica Biophysica Acta 2008, 1783(5):673-694.
42. Zanfolin M., Faro R., Araujo E.G., Guaraldo A.M., Antunes E., De Nucci G. Protective effects of BAY 41-2272 (sGC stimulator) on hypertension, heart, and cardiomyocyte hypertrophy induced by chronic l-NAME treatment in rats. Journal of Cardiovascular Pharmacology 2006, 47(3):391-395.
43. Zimmermann H. 5'-Nucleotidase: molecular structure and functional aspects. Biochemical Journal 1992, 285(Pt 2):345-365.
44. Zimmermann H. Ectonucleotidases: some recent developments and a note on nomenclature. Drug Development Research 2001, 52:44-56.